ICT-supported Multidimensional Approach for Frailty Screening in Community-dwelling Individuals Aged ≥ 65 Years
NCT ID: NCT05646472
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
700 participants
OBSERVATIONAL
2023-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Age-related Conditions in the Context of Multimorbidity and Frailty: Relative Weight of Frailty in Determining the Course and Outcomes of Different Chronic Diseases and Viceversa
NCT06324149
Education for Prevention and Treatment of Frailty
NCT05610605
Frailty Assessment and Treatment Strategies in the Elderly at Risk of Functional Decline in the Community
NCT03591055
Update on the Detection of Frailty in Older Adults
NCT06218121
Frailty in Daily Practice: Screening, Consultation and Education Activities
NCT04139837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
≥ 65 Community-dwelling older adults
Frailty multidimensional assessment
Each Centre will administer SUNFRAIL frailty assessment tool to the enrolled older adults and, according to the specific "alerts" triggered by the answers provided, older adults will be subjected (at the same time or subsequently) to one or more validated in-depth tests (already included in the SUNFRAIL+ platform) in order to perform further diagnostic or dimensional evaluations.
During the observation phase, subjects will be given different health promotion activities, depending on the assessment.
During the follow-up phase, 6 months after enrolment, SUNFRAIL tool and in-depth tests will be administered again. In addition, during the follow up, the extent to which exposure to interventions has influenced the quality of life of older adults will be measured and the number of users enrolled by territorial services, based on user care needs. In addition, the level of satisfaction and usability of the SUNFRAIL+ solution by health and social care professionals will be measured.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frailty multidimensional assessment
Each Centre will administer SUNFRAIL frailty assessment tool to the enrolled older adults and, according to the specific "alerts" triggered by the answers provided, older adults will be subjected (at the same time or subsequently) to one or more validated in-depth tests (already included in the SUNFRAIL+ platform) in order to perform further diagnostic or dimensional evaluations.
During the observation phase, subjects will be given different health promotion activities, depending on the assessment.
During the follow-up phase, 6 months after enrolment, SUNFRAIL tool and in-depth tests will be administered again. In addition, during the follow up, the extent to which exposure to interventions has influenced the quality of life of older adults will be measured and the number of users enrolled by territorial services, based on user care needs. In addition, the level of satisfaction and usability of the SUNFRAIL+ solution by health and social care professionals will be measured.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living at home;
* accessing participating centres for social and healthcare services other than those covered by this study;
* ability to sign the informed consent
Exclusion Criteria
* Residents in care facilities (hospital, nursing home);
* have overt frailty or disability; are already enrolled in home care; are unable to understand the study aims and sign the informed consent
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maddalena Illario
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Socio Sanitaria Territoriale della Valle Olona
Busto Arsizio, , Italy
Azienda Sanitaria Locale Cuneo 1
Cuneo, , Italy
Azienda Sociosanitaria Ligure n. 4
Genova, , Italy
Azienda Unità Sanitaria Locale Nord-Ovest
Lucca, , Italy
Azeidna Ospedaliera Universitaria Federico II
Napoli, , Italy
Cooperativa Sociale "Res Omnia"
Reggio Calabria, , Italy
Dipartimento di Biomedicina e Prevenzione dell'Università degli Studi di Roma Tor Vergata
Roma, , Italy
Azienda Provinciale Socio-Sanitaria Trento
Trento, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Marino Dell'Acqua
Role: primary
Paola Obbia
Role: primary
Walter Aronni
Role: primary
Moira Borgioli
Role: primary
Maddalena Illario
Role: primary
Fortunata Denisi
Role: primary
Giuseppe Liotta
Role: primary
Stefano Toccoli
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
De Luca V, Femminella GD, Leonardini L, Patumi L, Palummeri E, Roba I, Aronni W, Toccoli S, Sforzin S, Denisi F, Basso AM, Ruatta M, Obbia P, Rizzo A, Borgioli M, Eccher C, Farina R, Conforti D, Mercurio L, Salvatore E, Gentile M, Bocchino M, Sanduzzi Zamparelli A, Viceconte G, Gentile I, Ruosi C, Ferrara N, Fabbrocini G, Colao A, Triassi M, Iaccarino G, Liotta G, Illario M. Digital Health Service for Identification of Frailty Risk Factors in Community-Dwelling Older Adults: The SUNFRAIL+ Study Protocol. Int J Environ Res Public Health. 2023 Feb 21;20(5):3861. doi: 10.3390/ijerph20053861.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
284/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.